The paper was published in a journal that shut down after being overrun by paper mills.

Academics are not always aware of the standards — both explicit and implicit — that are used to assess them for promotion. We explore these expectations and more in this month’s issue of the Spectrum Launch newsletter.

The most prevalent conditions include obesity, neurological disorders, anxiety and attention-deficit/hyperactivity disorder.

A look back at NeuroDev’s first year gathering genomic and phenotypic data in Kenya and South Africa and a study on an underlying cause of repetitive behaviors in fragile X model mice absorbed researchers’ attention on social media this week. That and more in this week’s Community Newsletter.

The 4-year-old journal focuses on research that aims to improve the lives of autistic adults.

The New York State Psychiatric Institute in New York City is undergoing an audit and a change in leadership following a suicide that occurred during one of its clinical trials.

This month’s Going on Trial newsletter explores how organ-on-a-chip models could smooth the transition from preclinical to clinical trials, among other drug development news.

This week on social media, researchers discussed research on sensory issues in fragile X mice, and they considered yet another study of epidurals and autism. That and more in this week’s Community Newsletter.

Knocking down the gene that codes for the proteins normalizes the vocalizations.

A total of 17 studies have already been retracted or are slated for retraction over issues with participant consent.